The article "A genome-wide transcriptomic analysis of protein-coding genes in human blood cells" is published in the journal Science on December 19...Read more
Today it is announced that Horizon Discovery and the Human Protein Atlas have entered into partnership. The HPA Cell Atlas program will integrate Horizon's HAP1 cell line and has selected Horizon's CRISPR-edited knockout cell models to further expand the knowledge available in the Cell Atlas program...Read more
Today, a novel map of all proteins secreted to human blood is described. The paper by Uhlen et al. entitled "The Human Secretome" is published in the journal Science Signaling and provides a first comprehensive annotation of all proteins secreted by the human cells. In addition, an analysis of the concentrations of the proteins circulating in the human blood is described. This map provides a unique resource to study human biology and diseases, in particular for immune-based research and efforts to develop new, effective treatments in oncology and autoimmune diseases...Read more
A new Blood Atlas - a resource for exploration of blood cells and proteins - has been launched, as part of the open access Human Protein Atlas, in which the proteins in human blood cell types are described together with a comprehensive analysis of all proteins predicted to be secreted from human cells ("the secretome"). The new atlas provides a unique resource for the study of human biology and diseases, in particular for immune-based research and efforts to develop new, effective treatments in oncology and autoimmune diseases...Read more
A new Metabolic Atlas has been launched as part of the open access Human Protein Atlas program, allowing researchers to explore the expression of biochemical pathways across human tissues. The new resource leverages the most extensive mapping of human metabolism to date, with biochemical information and connectivity for more than 13,000 reactions, 4,000 unique compounds, and 3,500 genes...Read more
March 4, 2020 - March 7, 2020
Mathias Uhlén, Petter Brodin and Fredrik Edfors will participate in the World Immune Regulation Meeting XIV in Davos.